01/09/2026
What is society really getting from today’s drug innovation?
As healthcare budgets come under pressure, attention is shifting from simply adding more treatment to deploying therapies in a smarter, more targeted way that delivers clear value for patients and health systems.
In our latest article, we examine how innovation, AI and prevention can support more sustainable healthcare and where long‑term opportunities may emerge for investors. Read the article: What is society really getting from today’s drug innovation?
As healthcare budgets come under pressure, attention is shifting from simply adding more treatment to deploying therapies in a smarter, more targeted way that delivers clear value for patients and health systems. In our latest article, we examine how innovation, AI and prevention can support more sustainable healthcare and where long‑term opportunities may emerge for investors.
Read the article in our bio.